论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
东北地区青少年分泌型卷曲相关蛋白 5 与糖脂代谢相关代谢综合征成分的关系
Authors Bai Y, Du Q, Jiang R, Zhang L, Du R, Wu N, Li P, Li L
Received 13 January 2021
Accepted for publication 4 March 2021
Published 17 June 2021 Volume 2021:14 Pages 2735—2742
DOI https://doi.org/10.2147/DMSO.S301090
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Ming-Hui Zou
Purpose: Secreted frizzled-related protein 5 (SFRP5) is a novel anti-inflammatory adipokine that has been associated with various metabolic diseases. However, such relationship among adolescents remains unclear. The purpose of this study was to clarify the relationship between SFRP5 and the components of metabolic syndrome in Chinese adolescents.
Patients and Methods: In this cross-sectional study, we included a total of 684 adolescents aged 11– 16 years old from Liaoyang city, Liaoning province, China. The ELISA kits were implemented to measure the plasma SFRP5 and high-sensitivity C-reactive protein. Serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C), serum uric acid (UA), alanine aminotransferase (ALT), aspartate aminotransferase (AST), fasting plasma glucose (FPG), and fasting serum insulin (FINS) were also measured.
Results: The multivariate logistic regression analysis showed that low SFRP5 level were an independent risk factor of high FPG [odds ratio (OR)=5.31, 95% confidence interval (CI): 1.85– 15.22, P < 0.01] and high TC (OR=1.73, 95% CI: 1.01-2.96, P < 0.05) when adjusting for age, sex, family history of diabetes, body mass index, and high-sensitivity C-reactive protein.
Conclusion: The lower level of SFRP5 is strongly related to lipid and glucose metabolism among adolescents in Northeast China. The risk of high fasting plasma glucose and high total cholesterol increases significantly as the plasma SFRP5 level decreases.
Keywords: adolescents, secreted frizzled-related protein 5, metabolic syndrome, hyperglycemia, dyslipidemia